📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. (2014)

First Author: Phillips RO

Attributed to: R Phillips, KNUST Ghana. Pathogenesis and management of M. ulcerans disease, Buruli ulcer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.02165-13

PubMed Identifier: 24323473

Publication URI: http://europepmc.org/abstract/MED/24323473

Type: Journal Article/Review

Volume: 58

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 2

ISSN: 0066-4804